Advances in vaccine technology, antibody therapies, and genetic surveillance are giving researchers new tools to fight ...

The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...

Scientists have created the first new anti-malaria drug in quarter of a century in a bid to cut out resistance to existing treatments. Researchers found their new treatment has a “very high cure rate” ...

At the turn of the millennium, a new class of drugs derived from ancient Chinese herbal medicine revolutionized malaria care. Artemisinin's, as they're called, are based on extracts from the sweet ...

After decades of stalled progress, new vaccines, treatments and genetic tools are helping scientists protect children and ...

Please provide your email address to receive an email when new articles are posted on . Pyronaridine, a common malaria drug, has been used for more than 50 years. The agent could be repurposed to ...

In a historic move, Swissmedic has approved Coartem Baby, the first malaria treatment specifically for newborns and young ...

A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has ...

Patients who are infected with malaria and dengue virus receive treatment in an isolation ward at a hospital in Pakistan. Drugs known as artemisinins have been remarkably effective in helping malaria ...